Kala Bio Inc 's

• KALA's Stock Performance relative to its Competitors

Harrow Inc Share Performance -24.76% This Year

Harrow Inc Profile Harrow Health Inc's business model focuses on developing and commercializing innovative healthcare products and solutions, with a strong emphasis on specialty pharmaceuticals. More about Harrow Inc 's Market Share

Kiora Pharmaceuticals Inc Share Performance -3.49% 30 Days

Kiora Pharmaceuticals Inc Profile Kiora Pharmaceuticals Inc operates with a business model focused on the research, development, and commercialization of innovative pharmaceutical products for various medical conditions and diseases. The company aims to create value through the discovery of new drugs, rigorous clinical trials, and strategic partnerships for ultimate patient benefit and sustainable growth. More about Kiora Pharmaceuticals Inc 's Market Share

Legend Biotech Corporation Share Performance -40.51% One Year

Legend Biotech Corporation Profile Legend Biotech Corporation is a biotech company focused on developing innovative cell therapies and gene therapies to address unmet medical needs in various diseases. More about Legend Biotech Corporation's Market Share

Mineralys Therapeutics Inc Share Performance -18.89% One Year

Mineralys Therapeutics Inc Profile Mineralys Therapeutics Inc is a biotechnology company that follows the business model of developing and commercializing novel therapeutics for various diseases. They focus on discovering and advancing small molecule drugs based on innovative research approaches. Their business model is centered around conducting preclinical and clinical trials, obtaining regulatory approvals, and ultimately bringing their therapeutic products to market for improved patient outcomes. More about Mineralys Therapeutics Inc 's Market Share

Nektar Therapeutics Share Performance +2.19% Over The Past 5 Days

Nektar Therapeutics Profile Nektar Therapeutics operates under a business model focused on developing and commercializing innovative medicines. The company's approach involves utilizing its proprietary technology platforms to create novel therapeutic candidates and establish partnerships with pharmaceutical and biotechnology firms for clinical development and commercialization. Nektar Therapeutics aims to bring transformative therapies to market that address significant unmet medical needs. More about Nektar Therapeutics's Market Share

Sources: Kala Bio inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Thursday, September 10, 2026 1:21 PM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Kala Bio inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.